Stock EMMLD OKYO PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. OKYO Pharma Limited

Equities

EMMLD

GG00BMFG5F62

Market Closed - Nasdaq
Other stock markets
 02:00:00 08/06/2024 am IST 		5-day change 1st Jan Change
1.27 USD -5.22% Intraday chart for OKYO Pharma Limited -14.77% -28.25%
22/03 H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating MT
22/03 OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
H.C. Wainwright Adjusts Price Target on OKYO Pharma to $7 From $6, Maintains Buy Rating
MT
HC Wainwright Initiates Coverage on OKYO Pharma with Buy Rating, $4 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EMMLD Stock
  4. News OKYO Pharma Limited
  5. Analyst Reco.